Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Investigative Ophthalmology & Visual Science
|
January 31, 2002
Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies
Naheed Kanuga, Helen L Winton, Laurence Beauchéne, et al.
Stem Cells Translational Medicine
|
May 1, 2019
Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Karen Eastlake, Weixin Wang, Hari Jayaram, et al.
Investigative Ophthalmology & Visual Science
|
February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease
Scott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Plos One
|
June 27, 2013
Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model
Ian Catchpole, Volker Germaschewski, Jaimie Hoh Kam, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Investigative Ophthalmology & Visual Science
|
January 31, 2002
Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies
Naheed Kanuga, Helen L Winton, Laurence Beauchéne, et al.
Stem Cells Translational Medicine
|
May 1, 2019
Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Karen Eastlake, Weixin Wang, Hari Jayaram, et al.
Investigative Ophthalmology & Visual Science
|
February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease
Scott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Plos One
|
June 27, 2013
Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model
Ian Catchpole, Volker Germaschewski, Jaimie Hoh Kam, et al.
Page
of 2